Temmune Therapeutics
0776.938.722 · rovalta.com · 20/09/2026
ACTIVE
Temmune Therapeutics
Financial year 2025 · closed on 31/12/2025
Net result
-2,2 M €
-99.6% YoY
Gross margin
-377,0 k €
-17.0% YoY
Equity
2,0 M €
-9.5% YoY
Overview
What does Temmune Therapeutics do?
Temmune Therapeutics is a Public limited company incorporated in 2021. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Mechelen.
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0776.938.722
Incorporation
08/11/2021
Legal form
Public limited company
Registered office
Kardinaal Mercierplein 2
2800 Mechelen · FlandreSee on map
2800 Mechelen · FlandreSee on map
Contributed capital
4 347 047,79 €
Latest accounts
31/12/2025
Activities (NACE)
21201Manufacture of pharmaceutical preparations· main21201Manufacture of pharmaceutical preparations21209Manufacture of pharmaceutical preparations21209Manufacture of pharmaceutical preparations72101Research and experimental development on natural sciences and engineering72110Research and experimental development on biotechnology+2
Signals
Solid equityGood liquidity
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | -377,0 k € | -17.0% | -322,1 k € | +42.5% | -560,7 k € | +24.0% | -737,4 k € |
| EBITDA | -377,7 k € | -16.9% | -323,2 k € | +42.4% | -561,1 k € | +24.0% | -737,9 k € |
| Operating result | -2,3 M € | -82.5% | -1,2 M € | -121% | -561,1 k € | +24.0% | -737,9 k € |
| Net result | -2,2 M € | -99.6% | -1,1 M € | -96.2% | -564,6 k € | +24.2% | -744,7 k € |
| Balance sheet | |||||||
| Equity | 2,0 M € | -9.5% | 2,2 M € | +2059% | 103,0 k € | -55.3% | 230,3 k € |
| Total assets | 3,4 M € | +29.7% | 2,6 M € | +1238% | 197,9 k € | -28.5% | 276,6 k € |
| Cash | 1,5 M € | +172% | 538,1 k € | +300% | 134,4 k € | -51.3% | 276,1 k € |
| Debts | 1,4 M € | +235% | 423,6 k € | +347% | 94,8 k € | +105% | 46,4 k € |
Estimate
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 6 active · 6 ended
Active mandates
Tomas Heyman
ActiveActive
Dirk Reyn
ActiveKeith McCullagh
ActiveRoderick Verhelst
ActiveEnded mandates
Thomas Heyman
EndedTomas Heyman
EndedDirk Reyn
EndedKeith McCullugh
EndedAt this address
Other companies at this address
| Company | CBE no. |
|---|---|
| 1025.942.868 | |
ALL IN ONE DELIVERY● Bankrupt | 0691.693.043 |
Amber Therapeutics Belgium● Active | 1042.186.806 |
Anima● Active | 0696.648.852 |
ANIRES● Active | 1016.204.761 |
AVENO CARGO CENTER● Active | 0648.895.257 |
| 0802.924.725 | |
BENELUX & PARTNERS● Active | 0764.941.208 |
C&A ELECTRICITY● Bankrupt | 0797.043.258 |
CaptureAge● Active | 0734.747.383 |
CHARMEWONING● Bankrupt | 0826.369.328 |
Cybercontract● Active | 0557.948.651 |
Delgabre Group● Bankrupt | 0739.758.919 |
ESKENS BENELUX● Active | 0439.773.650 |
Foundation CaptureAge● Active | 1015.127.269 |
FRUTAROM BELGIUM● Active | 0403.593.145 |
HANOVER DISPLAYS● Active | 0737.945.118 |
HERA● Active | 0441.391.273 |
ICON Clinical Research Belgium● Active | 0467.032.927 |
JAMAIS-SANS-TOIT● Active | 1005.687.684 |
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 08/11/2021 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 14 months |
| Filing date | 07/04/2026 | 18/07/2025 | 18/07/2025 | 28/06/2023 |
| General meeting | 13/03/2026 | 16/07/2025 | 16/07/2025 | 23/06/2023 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
5 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 13/03/2026 | 07/04/2026 | Dutch | |
| Abridged model | 31/12/2024 | 16/07/2025 | 18/07/2025 | Dutch | |
| Abridged modelCorrection | 31/12/2023 | 16/07/2025 | 18/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 08/03/2024 | 26/03/2024 | Dutch | |
| Abridged model | 31/12/2022 | 23/06/2023 | 28/06/2023 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 6 active · 6 ended
Active mandates
Tomas Heyman
ActiveActive
Dirk Reyn
ActiveKeith McCullagh
ActiveRoderick Verhelst
ActiveEnded mandates
Thomas Heyman
EndedTomas Heyman
EndedDirk Reyn
EndedKeith McCullugh
EndedShareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
- Mandates20/03/2026ONTSLAGEN - BENOEMINGEN
- Mandates02/01/2026STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - ONTSLAGEN - BENOEMINGEN
- Mandates30/06/2025ONTSLAGEN - BENOEMINGEN
- Registered office30/01/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - MAATSCHAPPELIJKE ZETEL - KAPITAAL - AANDELEN
- Mandates30/09/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
- Registered office05/03/2024MAATSCHAPPELIJKE ZETEL
- Other10/11/2021RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-2,2 M €↓
- 2024Annual accounts 2024-1,1 M €↓
- 2023Annual accounts 2023-564,6 k €↑
- 2022Annual accounts 2022-744,7 k €
- 08/11/2021IncorporationPublic limited company